|
⚲
|
| Keyboard |
| Richards Christos
✚
|
|
|---|---|
| CIK # | 0001622055 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001622055] | |
| 4 | [0001622055] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Richards Christos | |
| Codexis Inc | |
| Coherus Oncology Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Codexis Inc CDXS
Common Stock
|
2025-06-10 | Grant | 40,983 | $0.00 | |
|
Codexis Inc CDXS
Common Stock
|
2025-01-14 | Grant | 44,150 | $0.00 | |
|
Coherus Oncology Inc CHRS
Stock Option (Right to Buy) · derivative
|
2020-01-10 | Grant | 20,000 | $0.00 | |
|
Coherus Oncology Inc CHRS
Stock Option (Right to Buy) · derivative
|
2019-01-11 | Grant | 20,000 | $0.00 | |
|
Coherus Oncology Inc CHRS
Stock Option (Right to Buy) · derivative
|
2018-02-01 | Grant | 20,000 | $0.00 | |
|
Coherus Oncology Inc CHRS
Stock Option (Right to Buy) · derivative
|
2017-05-17 | Grant | 20,000 | $0.00 | |
|
Coherus Oncology Inc CHRS
Stock Option (Right to Buy) · derivative
|
2016-05-24 | Grant | 10,000 | $0.00 | |
|
Coherus Oncology Inc CHRS
Common Stock, $0.0001 par value
|
2015-11-13 | Sell | 4,012 | $27.93 | 112,055 |
|
Coherus Oncology Inc CHRS
Common Stock, $0.0001 par value
|
2015-11-13 | Sell | 7,988 | $27.38 | 218,711 |
|
Coherus Oncology Inc CHRS
Common Stock, $0.0001 par value
|
2015-11-12 | Sell | 3,000 | $27.23 | 81,690 |
|
Coherus Oncology Inc CHRS
Stock Option (Right to Buy) · derivative
|
2015-04-01 | Grant | 20,000 | $0.00 | |
|
Coherus Oncology Inc CHRS
Common Stock, $0.0001 par value
|
2014-11-12 | Conversion | 12,672 | ||
|
Coherus Oncology Inc CHRS
Common Stock, $0.0001 par value
|
2014-11-12 | Conversion | 39,991 | ||
|
Coherus Oncology Inc CHRS
Common Stock, $0.0001 par value
|
2014-11-12 | Other | 2,956 | ||
|
Coherus Oncology Inc CHRS
Warrant to Purchase Common Stock · derivative
|
2014-11-12 | Option exercise | 26,505 | $0.00 | |
|
Coherus Oncology Inc CHRS
Warrant to Purchase Series B Preferred Stock · derivative
|
2014-11-12 | Option exercise | 429 | $0.00 | |
|
Coherus Oncology Inc CHRS
Common Stock, $0.0001 par value
|
2014-11-12 | Option exercise | 26,505 | $1.67 | 44,263 |
|
Coherus Oncology Inc CHRS
Series B Preferred Stock · derivative
|
2014-11-12 | Other | 1 | ||
|
Coherus Oncology Inc CHRS
Series A Preferred Stock · derivative
|
2014-11-12 | Conversion | 39,991 | ||
|
Coherus Oncology Inc CHRS
Series B Preferred Stock · derivative
|
2014-11-12 | Conversion | 12,672 | ||
| showing 20 of 23 most recent transactions | |||||